Canada Urology Devices Market Overview,2030

The urology devices market in Canada has developed into one of North America’s most technologically progressive healthcare sectors, supported by a strong mix of public investment, medical research, and clinical innovation. The market’s growth stems from the integration of minimally invasive surgical systems and digital health solutions that have reshaped patient management in hospitals such as Toronto General Hospital and Vancouver General Hospital. The field of urology in Canada has transitioned from traditional endoscopic methods to advanced fiber-optic and flexible systems that provide superior visualization for diagnostic and therapeutic use. Developments at institutions like the University Health Network in Toronto have advanced the use of robotic-assisted surgery, particularly for prostate and kidney procedures. Canada’s aging population, where over 19 percent are over the age of 65 according to Statistics Canada, is a major driver for increased procedures related to prostate enlargement, incontinence, and renal complications. The country has also seen the rapid adoption of home-based urology devices, including intermittent catheters and portable dialysis machines, which are now commonly used in provinces such as Ontario and British Columbia through telehealth programs supported by the Canadian Urological Association. Artificial intelligence and imaging technologies are increasingly being integrated into clinical diagnostics, as seen in collaborations between McGill University Health Centre and Siemens Healthineers for predictive analytics in prostate cancer detection. The introduction of smart catheters and wearable urinary monitoring sensors by innovators like Exact Imaging in Markham has improved chronic disease management. Regulatory oversight is maintained by Health Canada under the Medical Devices Regulations, ensuring compliance with ISO and FDA-equivalent standards. Hospitals have intensified their focus on infection control, favoring disposable cystoscopes and catheters to reduce cross-contamination risks. Combined with eco-friendly packaging, waste reduction programs, and robust cloud-based data security systems, these advancements position Canada’s urology devices ecosystem as an integrated, forward-moving segment of national healthcare modernization.

According to the research report, ""Canada Urology Devices Market Overview, 2030,"" published by Bonafide Research, the Canada Urology Devices market is anticipated to grow at more than 7.07% CAGR from 2025 to 2030. Major hospitals such as Sunnybrook Health Sciences Centre and St. Michael’s Hospital have expanded day-care and outpatient urology units, adopting laser and endoscopic systems that enable same-day discharge and faster recovery. Robotic surgery adoption has accelerated with platforms like the da Vinci system by Intuitive Surgical now used at multiple centers, including the Montreal General Hospital for prostatectomies and kidney surgeries. Canadian manufacturers and distributors such as Laborie Medical Technologies in Mississauga play a vital role by producing urodynamic systems and diagnostic instruments that are exported to international markets. Strategic collaborations between Laborie, Baylis Medical, and Boston Scientific have strengthened Canada’s presence in the global urology device supply chain. The market benefits from strong public funding under the Canada Health Act, with provincial health ministries such as Alberta Health and Ontario Health supporting reimbursement for major urological procedures. Insurance coverage through the Canadian Life and Health Insurance Association further ensures patient access to high-cost treatments involving advanced devices. Emerging startups like Flosonics Medical and Exact Imaging are developing wearable sensors and AI-based imaging tools that support early disease detection and remote patient monitoring. Academic partnerships between the University of Toronto, Dalhousie University, and GE Healthcare are advancing 3D printing of customized surgical instruments and implants. Canada’s import channels for urology equipment are streamlined through the Medical Device Establishment Licence framework, facilitating distribution by companies like Medline Canada and Cardinal Health. Hospitals are increasingly renting high-cost devices through leasing programs managed by equipment finance providers such as CSI Leasing, reducing budget pressure on healthcare facilities.

In the Canadian urology devices market the Product category includes high-technology instruments such as rigid and flexible cystoscopes, ureteroscopes used in centres like Toronto’s University Health Network or Vancouver General Hospital for bladder and ureter visualisation and intervention, as well as laser and lithotripsy systems installed in provinces like Alberta and Quebec for kidney stone fragmentation and removal, and advanced dialysis machines used in urology-nephrology integrated units. Canadian hospitals routinely acquire flexible ureteroscopes with digital imaging capabilities from manufacturers such as Karl Storz and Olympus Corporation, and laser platforms from companies like Boston Scientific Corporation for minimally invasive prostate and stone procedures. The Accessories segment spans consumables including Foley catheters, intermittent catheters, external drainage bags and ureteral stents often supplied by firms like Cook Medical or Teleflex Incorporated used in Canadian urology units and long-term care facilities. Lubricants and gels used in cystoscopic and catheterisation procedures are also key components of the accessories portfolio. Canadian regulatory oversight by Health Canada and infection-control requirements have influenced adoption of more single-use accessories and re-sterilised components in urology practice across centres such as the Montreal General Hospital. In Canada the interplay between capital-equipment purchases (endoscopes, lasers, dialysis units) and recurring-consumable accessory spend (catheters, stents, gels) defines procurement strategies in both public and private healthcare settings, seeking to balance procedural throughput and cost-effectiveness while meeting safety and regulatory demands.

In Canada the urology devices market addresses a range of clinical applications beginning with urolithiasis (stone disease) where centres such as the Foothills Medical Centre in Calgary employ flexible ureteroscopes, holmium-laser lithotripsy systems, and nephroscopes to manage kidney and ureteral stones, reflecting rising incidence in younger adult cohorts. The treatment of benign prostatic hyperplasia (BPH) sees deployment of technologies like laser vaporisation and prostate resection devices in hospitals in Ontario and British Columbia, addressing urinary obstruction in aging male populations. For urological cancers including prostate, bladder and renal cancers Canadian academic hospitals such as the Ottawa Hospital use endoscopic resection equipment, imaging-guided ablation devices and robotic-assisted platforms to perform tumour removal and staging. When it comes to urinary incontinence & pelvic organ prolapse, Canadian urology and uro-gynecology practices employ slings, artificial urinary sphincters and implants, particularly in post-prostatectomy patients or older women in the Atlantic provinces. In erectile dysfunction management Canadian clinics provide penile prostheses and implantable devices for refractory cases, often sourced through national urology device distributors. Kidney diseases such as chronic kidney disease and end-stage renal failure require dialysis devices and related urology/renal equipment in renal-urology units throughout Canada, particularly in Saskatchewan and Manitoba where nephrology-urology overlap is critical. Finally other applications including paediatric urology (e.g., congenital urethral strictures), urethral infections requiring diagnostic scopes, and anatomical anomalies in remote Northern communities deploy specialised small-calibre cystoscopes and catheter systems.

In Canada the urology devices market divides across three principal end-use settings such as hospitals and clinics, dialysis centres, and home care settings. In the hospitals and clinics segment major tertiary hospitals in cities like Toronto, Vancouver and Montreal install comprehensive urology suites equipped with diagnostic and surgical devices including high-definition cystoscopes, ureteroscopes, laser lithotripters and stent placement systems. These environments cater to high procedural volumes, complex urology surgeries and training of specialists. In the dialysis centres segment regional facilities in Alberta and Ontario integrate urology/renal devices such as haemodialysis machines, vascular access tools, drainage systems and monitoring equipment in collaboration with urology departments to manage patients with combined renal and urinary tract disorders. Home dialysis machines, external urinary catheters and long-term drainage systems are increasingly offered in these centres. In the home care settings segment Canadian patients use devices in their residences such as intermittent self-catheterisation kits, portable urine drainage bags and at-home dialysis units, particularly in rural provinces like Newfoundland & Labrador where travel to major centres is difficult. Canadian home-care providers supply disposable catheters and accessories and coordinate with urology clinics for supervised remote device usage. Across all end-use settings Canadian reimbursement frameworks under provincial health plans, combined with infection-control imperatives and public-health strategies, shape how urology devices are procured by hospitals, deployed in dialysis centres and supported for home-based care. 

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Urology Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Product
• Accessories

By Application
• Urolithiasis (Stone Disease)
• Benign Prostatic Hyperplasia (BPH)
• Urological Cancers
• Urinary Incontinence & Pelvic Organ Prolapse
• Erectile Dysfunction
• Kidney Diseases
• Other Applications (Pediatrics, Strictures, Infections, etc.)

By End Use
• Hospitals and clinics
• Dialysis centers
• Others (Home care settings) Show more